IFG Advisory LLC Sells 4,071 Shares of CVS Health Corporation $CVS

IFG Advisory LLC lowered its position in CVS Health Corporation (NYSE:CVS) by 22.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,985 shares of the pharmacy operator’s stock after selling 4,071 shares during the period. IFG Advisory LLC’s holdings in CVS Health were worth $965,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Avion Wealth boosted its holdings in CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares during the period. Harbor Asset Planning Inc. bought a new position in shares of CVS Health during the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc boosted its holdings in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Roxbury Financial LLC boosted its holdings in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC boosted its holdings in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.22% of the company’s stock.

CVS Health Stock Up 1.9%

CVS stock opened at $78.13 on Friday. The stock has a market capitalization of $99.18 billion, a P/E ratio of 205.61, a P/E/G ratio of 0.87 and a beta of 0.60. The firm has a 50-day simple moving average of $76.49 and a 200-day simple moving average of $69.04. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the previous year, the company earned $1.09 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio is currently 700.00%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CVS. Raymond James Financial upped their target price on shares of CVS Health from $75.00 to $90.00 in a research report on Friday. Cantor Fitzgerald upped their target price on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. The Goldman Sachs Group initiated coverage on shares of CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Finally, Piper Sandler raised their price target on shares of CVS Health from $81.00 to $99.00 in a report on Friday. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $87.64.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.